Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
osu1135261379.pdf (1.87 MB)
ETD Abstract Container
Abstract Header
Optimize the generation and depletion of alloreactive T cells for cellular therapy
Author Info
Shao, Mei
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=osu1135261379
Abstract Details
Year and Degree
2005, Doctor of Philosophy, Ohio State University, Chemical Engineering.
Abstract
Stem cell transplantation and high-dose chemotherapy is the most effective treatment for certain cancers such as leukemia and lymphoma. It is reported from the leukemia and lymphoma society that there are about 28,540 new cases of leukemia and 54,370 cases of non-Hodgkin lymphoma are diagnosed each year in the United States. Allogeneic stem cell transplantation has been widely studied due to the lack of HLA (Human Leukocyte Antigen)-matched donors. However, the application of allogeneic stem cell transplantation is restricted by the development of severe graft-versus-host disease (GvHD), which is believed to be caused by donor T cells. Depletion of donor T cells abrogates GvHD, while the chance of viral infection and leukemia relapse is increased due to the delay of immuno-reconstitution after extensive T cell depletion. Selective depletion of alloreactive T cells which mediate GvHD from donors, while retaining T cells with reactivity to pathogens and third party antigens is an alternative strategy that may protect the patient from opportunistic infections and shorten the immunodeficiency post transplantation. However, the success of this strategy depends on the extent of alloreactive T cell depletion and remaining anti-viral and third party reactivity. One of the main challenges associated with inefficient alloreactive T cell depletion is the stimulation and detection of potential alloreactive T cells.This study is focusing optimizing the condition for generating alloreactive T cells in vitro; selection of the optimum combination of activation antigens to define alloreactive T cells; and applying immunomagnetic cell separation method to maximize depletion of alloreactivity with the preservation of anti-third-party reactivity for clinical application.
Committee
Jeffrey Chalmers (Advisor)
Keywords
CD25
;
ALLOREACTIVE T CELLS
;
ALLOREACTIVE
;
CD69
;
CELLS
;
activation antigens
;
HLADR
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Shao, M. (2005).
Optimize the generation and depletion of alloreactive T cells for cellular therapy
[Doctoral dissertation, Ohio State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=osu1135261379
APA Style (7th edition)
Shao, Mei.
Optimize the generation and depletion of alloreactive T cells for cellular therapy.
2005. Ohio State University, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=osu1135261379.
MLA Style (8th edition)
Shao, Mei. "Optimize the generation and depletion of alloreactive T cells for cellular therapy." Doctoral dissertation, Ohio State University, 2005. http://rave.ohiolink.edu/etdc/view?acc_num=osu1135261379
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
osu1135261379
Download Count:
1,235
Copyright Info
© 2005, all rights reserved.
This open access ETD is published by The Ohio State University and OhioLINK.